{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:00:58Z","timestamp":1774645258241,"version":"3.50.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00604","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T08:57:13Z","timestamp":1567069033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance"],"prefix":"10.3389","volume":"10","author":[{"given":"Francesca Marta","family":"Elli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"de Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Madeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Maffini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bordogna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Pirelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrendo.2016.52","article-title":"Pseudohypoparathyroidism and Gs\u03b1-cAMP-linked disorders: current view and open issues","volume":"12","author":"Mantovani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B2","first-page":"922","article-title":"Pseudohypoparathyroidism-an example of \u201cSeabright-Bantam syndrome\u201d","volume":"30","author":"Albright","year":"1942","journal-title":"Endocrinology"},{"key":"B3","first-page":"337","article-title":"Pseudo-pseudohypoparathyroidism","volume":"65","author":"Albright","year":"1952","journal-title":"Trans. Assoc. Am. Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40618-016-0588-4","article-title":"Pseudohypoparathyroidism: one gene, several syndromes","volume":"40","author":"Tafaj","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1210\/jc.2011-1048","article-title":"Clinical review: Pseudohypoparathyroidism: diagnosis and treatment","volume":"96","author":"Mantovani","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/bonekey.2012.225","article-title":"Acrodysostosis syndromes","volume":"1","author":"Silve","year":"2012","journal-title":"Bonekey Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-16-0107","article-title":"From pseudohypoparathyroidism to inactivating PTH\/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network","volume":"175","author":"Thiele","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/jpem-2012-0375","article-title":"Brachydactyly mental retardation syndrome in the differential diagnosis of pseudopseudohypoparathyroidism","volume":"26","author":"Hacihamdioglu","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.c.30153","article-title":"Chromosome 2q37 deletion: clinical and molecular aspects","author":"Falk","year":"2007","journal-title":"Am J Med Genet Part C"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E508","DOI":"10.1210\/jc.2013-3086","article-title":"Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations","volume":"99","author":"Elli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/humu.22265","article-title":"Pseudohypoparathyroidism Type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations","volume":"34","author":"Elli","year":"2013","journal-title":"Hum Mutat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/jbmr.2785","article-title":"Screening of PRKAR1A and PDE4D in a large italian series of patients clinically diagnosed with albright hereditary osteodystrophy and\/or pseudohypoparathyroidism","volume":"31","author":"Elli","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ajmg.a.30199","article-title":"Molecular characterization of a cryptic 2q37 deletion in a patient with Albright hereditary osteodystrophy-like phenotype","author":"Chassaing","year":"2004","journal-title":"Am J Med Genet A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1399-0004.2004.00363.x","article-title":"Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype","volume":"66","author":"Shrimpton","year":"2004","journal-title":"Clin Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ajmg.a.32779","article-title":"FARP2, HDLBP and PASK are downregulated in a patient with autism and 2q37.3 deletion syndrome","author":"Felder","year":"2009","journal-title":"Am J Med Genet A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajhg.2010.07.011","article-title":"Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems","volume":"87","author":"Williams","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/ajmg.a.35463","article-title":"Dose dependent expression of HDAC4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome","author":"Morris","year":"2012","journal-title":"Am J Med. Genet A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13148-018-0607-8","article-title":"Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B\/iPPSD3","volume":"11","author":"Elli","year":"2019","journal-title":"Clin Epigenet"},{"key":"B20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jmg.34.4.287","article-title":"RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37","volume":"34","author":"Power","year":"1997","journal-title":"J Med Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00604\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T08:44:39Z","timestamp":1569055479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00604\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":20,"alternative-id":["10.3389\/fendo.2019.00604"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00604","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"article-number":"604"}}